品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
阿拉丁 | A129800-5mg | 5mg | 现货 | 959122-11-3 |
A922500,DGAT-1抑制剂 A922500 |
≥98% |
|
|
阿拉丁 | A129800-10mg | 10mg | 现货 | 959122-11-3 |
A922500,DGAT-1抑制剂 A922500 |
≥98% |
|
|
阿拉丁 | A129800-50mg | 50mg | 现货 | 959122-11-3 |
A922500,DGAT-1抑制剂 A922500 |
≥98% |
|
|
阿拉丁 | A129800-1mg | 1mg | 现货 | 959122-11-3 |
A922500,DGAT-1抑制剂 A922500 |
≥98% |
|
|
阿拉丁 | A129800-100mg | 100mg | 现货 | 959122-11-3 |
A922500,DGAT-1抑制剂 A922500 |
≥98% |
|
|
阿拉丁 | A408455-1ml | 1ml | 现货 | 959122-11-3 |
A922500 A922500 |
10mM in DMSO |
|
|
梯希爱 | D5994-10MG | 10MG | 现货 | 959122-11-3 |
(1R,2R)-2-[4'-(3-苯基脲基)-[1,1'... A 922500 |
95.0% |
|
|
毕得 | BD215766-50mg | 50mg | 现货 | 959122-11-3 |
(1R,2R)-2-(4'-(3-苯基脲基)-[1,1'... (1R,2R)-2-(4'-(3-Phenylureid... |
98% |
|
|
毕得 | BD215766-100mg | 100mg | 现货 | 959122-11-3 |
(1R,2R)-2-(4'-(3-苯基脲基)-[1,1'... (1R,2R)-2-(4'-(3-Phenylureid... |
98% |
|
|
毕得 | BD215766-25mg | 25mg | 现货 | 959122-11-3 |
(1R,2R)-2-(4'-(3-苯基脲基)-[1,1'... (1R,2R)-2-(4'-(3-Phenylureid... |
98% |
|
|
罗恩 | R023234-5mg | 5mg | 5~7个工作日 | 959122-11-3 |
(1R,2R)-2-[[4-[[(苯基氨基)羰基]氨基]... (1R,2R)-2-[4-[4-(phenylcarba... |
99% |
|
|
罗恩 | R023234-1mg | 1mg | 现货 | 959122-11-3 |
(1R,2R)-2-[[4-[[(苯基氨基)羰基]氨基]... (1R,2R)-2-[4-[4-(phenylcarba... |
99% |
|
|
罗恩 | R023234-25mg | 25mg | 现货 | 959122-11-3 |
(1R,2R)-2-[[4-[[(苯基氨基)羰基]氨基]... (1R,2R)-2-[4-[4-(phenylcarba... |
99% |
|
|
罗恩 | R023234-100mg | 100mg | 5~7个工作日 | 959122-11-3 |
(1R,2R)-2-[[4-[[(苯基氨基)羰基]氨基]... (1R,2R)-2-[4-[4-(phenylcarba... |
99% |
|
|
麦克林2025 | A872309-1mg | 1mg | 8.000 | 959122-11-3 |
A922500 A922500 |
99% |
|
|
麦克林2025 | A872309-5mg | 5mg | 5.000 | 959122-11-3 |
A922500 A922500 |
99% |
|
|
麦克林2025 | A872309-25mg | 25mg | 7.000 | 959122-11-3 |
A922500 A922500 |
99% |
|
|
麦克林2025 | A872309-100mg | 100mg | 7个工作日 | 959122-11-3 |
A922500 A922500 |
99% |
|
|
麦克林2025 | A798021-1ml | 1ml | 10个工作日 | 959122-11-3 |
A922500 A922500 |
10mM in DMSO |
|
|
源叶 | S81170-5mg | 5mg | 现货 | 959122-11-3 |
DGAT-1 inhibitor DGAT-1 inhibito |
98% |
|
|